Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLBD1 antisense RNA 1 (PLBD1-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 12, transcribed antisense to the PLBD1 protein-coding gene[1][3][4][9]. It does not encode a protein. While the exact function of PLBD1-AS1 is unknown, current research suggests it may play a role in regulating gene expression, potentially by affecting the stability or translation of PLBD1 messenger RNA, but specific molecular mechanisms and biological significance remain uncharacterized[3][9]. PLBD1-AS1 is not a therapeutic target such as a receptor, enzyme, or transporter, and there are no known interacting drugs, mechanisms of drug action, or biomarker associations at this time[3][4][9]. There is a correlative disease association with meconium ileus, but no direct evidence for a pathogenic or functional role in disease[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PLBD1 antisense RNA 1 (PLBD1-AS1).